S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Antero Resources Co. stock logo
AR
Antero Resources
$28.86
-1.0%
$26.71
$19.91
$30.90
$8.76B3.34.78 million shs3.85 million shs
Boston Scientific Co. stock logo
BSX
Boston Scientific
$67.42
-0.8%
$67.21
$48.35
$69.21
$98.91B0.786.37 million shs5.95 million shs
Gold Standard Ventures Corp stock logo
GSV
Gold Standard Ventures
$0.40
$0.00
$0.27
$0.55
$144.21M1.02580,077 shsN/A
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
$53.20
$0.00
$44.11
$60.50
$21.28MN/A3,929 shs5,990 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Antero Resources Co. stock logo
AR
Antero Resources
-1.05%-4.45%+10.68%+31.70%+24.48%
Boston Scientific Co. stock logo
BSX
Boston Scientific
-0.79%-2.06%-0.55%+10.60%+27.47%
Gold Standard Ventures Corp stock logo
GSV
Gold Standard Ventures
0.00%0.00%0.00%0.00%0.00%
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
0.00%0.00%0.00%0.00%+0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Antero Resources Co. stock logo
AR
Antero Resources
3.4556 of 5 stars
2.33.00.01.12.02.52.5
Boston Scientific Co. stock logo
BSX
Boston Scientific
4.3831 of 5 stars
2.53.00.04.23.12.52.5
Gold Standard Ventures Corp stock logo
GSV
Gold Standard Ventures
N/AN/AN/AN/AN/AN/AN/AN/A
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Antero Resources Co. stock logo
AR
Antero Resources
2.54
Moderate Buy$30.696.37% Upside
Boston Scientific Co. stock logo
BSX
Boston Scientific
3.00
Buy$68.501.60% Upside
Gold Standard Ventures Corp stock logo
GSV
Gold Standard Ventures
N/AN/AN/AN/A
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
0.00
N/AN/AN/A

Current Analyst Ratings

Latest PAF, GSV, BSX, AR, and RND Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/17/2024
Antero Resources Co. stock logo
AR
Antero Resources
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$26.00 ➝ $36.00
4/15/2024
Antero Resources Co. stock logo
AR
Antero Resources
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$26.00 ➝ $27.00
4/15/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$70.00 ➝ $78.00
4/11/2024
Antero Resources Co. stock logo
AR
Antero Resources
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$26.00 ➝ $36.00
4/10/2024
Antero Resources Co. stock logo
AR
Antero Resources
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$32.00
4/5/2024
Antero Resources Co. stock logo
AR
Antero Resources
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$28.00 ➝ $27.00
4/4/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$68.00 ➝ $72.00
4/3/2024
Antero Resources Co. stock logo
AR
Antero Resources
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$28.00 ➝ $29.00
4/3/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$71.00 ➝ $79.00
4/3/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$69.00 ➝ $80.00
3/28/2024
Antero Resources Co. stock logo
AR
Antero Resources
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$24.00 ➝ $26.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Antero Resources Co. stock logo
AR
Antero Resources
$4.68B1.87$2.72 per share10.61$24.00 per share1.20
Boston Scientific Co. stock logo
BSX
Boston Scientific
$14.24B6.95$2.87 per share23.47$13.33 per share5.06
Gold Standard Ventures Corp stock logo
GSV
Gold Standard Ventures
N/AN/AN/AN/A$0.63 per shareN/A
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Antero Resources Co. stock logo
AR
Antero Resources
$242.92M$0.7737.4710.49N/A5.19%2.10%1.09%4/24/2024 (Confirmed)
Boston Scientific Co. stock logo
BSX
Boston Scientific
$1.59B$1.0763.0126.542.3911.19%15.99%8.87%4/24/2024 (Confirmed)
Gold Standard Ventures Corp stock logo
GSV
Gold Standard Ventures
-$8.74M-$0.03N/AN/AN/AN/A-3.87%-3.78%N/A
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
N/AN/A0.00N/AN/AN/AN/AN/A

Latest PAF, GSV, BSX, AR, and RND Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/24/2024N/A
Antero Resources Co. stock logo
AR
Antero Resources
$0.0010N/A-$0.0010N/AN/AN/A  
4/24/2024N/A
Boston Scientific Co. stock logo
BSX
Boston Scientific
$0.51N/A-$0.51N/AN/AN/A  
2/14/2024Q4 2023
Antero Resources Co. stock logo
AR
Antero Resources
$0.18$0.22+$0.04$0.14$1.17 billion$1.19 billion
1/31/2024Q4 23
Boston Scientific Co. stock logo
BSX
Boston Scientific
$0.51$0.55+$0.04$0.76$3.59 billion$3.73 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Antero Resources Co. stock logo
AR
Antero Resources
N/AN/AN/AN/AN/A
Boston Scientific Co. stock logo
BSX
Boston Scientific
N/AN/AN/AN/AN/A
Gold Standard Ventures Corp stock logo
GSV
Gold Standard Ventures
N/AN/AN/AN/AN/A
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
$2.113.97%N/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Antero Resources Co. stock logo
AR
Antero Resources
0.21
0.33
0.33
Boston Scientific Co. stock logo
BSX
Boston Scientific
0.44
1.32
0.82
Gold Standard Ventures Corp stock logo
GSV
Gold Standard Ventures
N/A
21.71
21.71
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
N/AN/AN/A

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Antero Resources Co. stock logo
AR
Antero Resources
604303.57 million285.51 millionOptionable
Boston Scientific Co. stock logo
BSX
Boston Scientific
48,0001.47 billion1.46 billionOptionable
Gold Standard Ventures Corp stock logo
GSV
Gold Standard Ventures
20358.74 millionN/ANot Optionable
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
N/A400,000N/ANot Optionable

PAF, GSV, BSX, AR, and RND Headlines

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Antero Resources logo

Antero Resources

NYSE:AR
Antero Resources Corporation, an independent oil and natural gas company, engages in the development, production, exploration, and acquisition of natural gas, natural gas liquids (NGLs), and oil properties in the United States. It operates in three segments: Exploration and Development; Marketing; and Equity Method Investment in Antero Midstream. As of December 31, 2023, the company had approximately 515,000 net acres in the Appalachian Basin; and approximately 172,000 net acres in the Upper Devonian Shale. Its gathering and compression systems also comprise 631 miles of gas gathering pipelines in the Appalachian Basin. The company was formerly known as Antero Resources Appalachian Corporation and changed its name to Antero Resources Corporation in June 2013. Antero Resources Corporation was incorporated in 2002 and is headquartered in Denver, Colorado.
Boston Scientific logo

Boston Scientific

NYSE:BSX
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Gold Standard Ventures logo

Gold Standard Ventures

NYSEAMERICAN:GSV
Gold Standard Ventures Corp., an exploration stage company, engages in the development of district-scale and other gold-bearing mineral resource properties in Nevada, the United States. Its flagship property is the Railroad-Pinion project covering an area of approximately 53,570 acres located in the Elko County, Nevada. The company was incorporated in 2004 and is headquartered in Vancouver, Canada. As of August 12, 2022, Gold Standard Ventures Corp operates as a subsidiary of Orla Mining Ltd.

Invesco FTSE RAFI Asia Pac ex-Jpn ETF

NYSEARCA:PAF
PowerShares FTSE RAFI Asia Pacific ex-Japan Portfolio (the Fund) is based on the FTSE RAFI Developed Asia Pacific ex Japan Index (Index). The Fund will normally invest at least 90% of its total assets in securities that comprise the Index and American Depositary Receipts (ADRs) based on the securities in the Index. The Index is designed to track the performance of the largest equities of companies domiciled in the Asia Pacific region (excluding Japan), selected based on the four fundamental measures of firm size: book value, income, sales and dividends. The 1000 equities with the highest fundamental strength are weighted according to their fundamental scores. The fundamentally weighted portfolio is rebalanced and reconstituted annually. The Fund invests in consumer discretionary, consumer staples, energy, financials, health care, industrials, information technology and telecommunicaiton services sectors. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.